These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29137292)
1. The clinical significance of Ma X; Wu Y; Zhang T; Song H; Jv H; Guo W; Ren G Oncotarget; 2017 Oct; 8(47):82661-82673. PubMed ID: 29137292 [No Abstract] [Full Text] [Related]
2. Ki67 Proliferation Index as a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients without Distant Metastases. Ma X; Wu Y; Zhang T; Song H; Jv H; Guo W; Ren G J Cancer; 2017; 8(18):3828-3837. PubMed ID: 29151970 [No Abstract] [Full Text] [Related]
3. Novel somatic KIT exon 8 mutation with dramatic response to imatinib in a patient with mucosal melanoma: a case report. Rapisuwon S; Parks K; Al-Refaie W; Atkins MB Melanoma Res; 2014 Oct; 24(5):509-11. PubMed ID: 25003536 [TBL] [Abstract][Full Text] [Related]
4. Pathological activation of KIT in metastatic tumors of acral and mucosal melanomas. Ashida A; Takata M; Murata H; Kido K; Saida T Int J Cancer; 2009 Feb; 124(4):862-8. PubMed ID: 19035443 [TBL] [Abstract][Full Text] [Related]
13. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors. Papaspyrou G; Garbe C; Schadendorf D; Werner JA; Hauschild A; Egberts F Melanoma Res; 2011 Dec; 21(6):475-82. PubMed ID: 21897303 [TBL] [Abstract][Full Text] [Related]
14. Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis. Willmore-Payne C; Holden JA; Tripp S; Layfield LJ Hum Pathol; 2005 May; 36(5):486-93. PubMed ID: 15948115 [TBL] [Abstract][Full Text] [Related]
15. Large-scale analysis of PDGFRA mutations in melanomas and evaluation of their sensitivity to tyrosine kinase inhibitors imatinib and crenolanib. Dai J; Kong Y; Si L; Chi Z; Cui C; Sheng X; Mao L; Li S; Lian B; Yang R; Liu S; Xu X; Guo J Clin Cancer Res; 2013 Dec; 19(24):6935-42. PubMed ID: 24132921 [TBL] [Abstract][Full Text] [Related]
16. Anal mucosal melanoma with KIT-activating mutation and response to imatinib therapy--case report and review of the literature. Satzger I; Küttler U; Völker B; Schenck F; Kapp A; Gutzmer R Dermatology; 2010; 220(1):77-81. PubMed ID: 19996579 [TBL] [Abstract][Full Text] [Related]